Vivani Medical Inc [VANI] stock is trading at $2.47, down -20.06%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VANI shares have gain 140.98% over the last week, with a monthly amount glided 137.50%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 1, March 2024, Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants. In a post published today on Yahoo Finance, Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced that it has entered into a securities purchase agreement with an institutional investor to purchase 3,947,368 shares of common stock and warrants to purchase up to an aggregate of 3,947,368 shares of common stock at a purchase price of $3.80 per share and accompanying warrant in a registered direct offering. The warrants have an exercise price of $3.80 per share, are exercisable immediately upon issuance, and will expire three years following the date of issuance.
From an analyst’s perspective:
Vivani Medical Inc [VANI] stock has fluctuated between $0.75 and $7.80 over the past year. Vivani Medical Inc [NASDAQ: VANI] shares were valued at $2.47 at the most recent close of the market.
Analyzing the VANI fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.49, Equity is -0.74 and Total Capital is -0.62. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.22 points at the first support level, and at 1.98 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.86, and for the 2nd resistance point, it is at 3.26.
Vivani Medical Inc [VANI] reported earnings per share of -$0.13 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.13/share, meaning a difference of $0 and a surprise factor of 0.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.13 per share as compared to estimates of -$0.11 per share, a difference of -$0.02 representing a surprise of -18.20%.
Ratios To Look Out For
For context, Vivani Medical Inc’s Current Ratio is 4.13. Further, the Quick Ratio stands at 4.13, while the Cash Ratio is 3.34.
Transactions by insiders
Insider trading, which has resulted in 1 insider purchases of 100 shares and 0 insider sales of 0 shares in the past three months, is now the topic of our analysis. Recent insider trading involved Williams Gregg, Director, that happened on Feb 15 when 1078.0 shares were purchased. Director, Williams Gregg completed a deal on Feb 09 to buy 1071.0 shares. Meanwhile, Director Williams Gregg bought 1119.0 shares on Feb 08.
